Company intelligence / Profile preview

FitBiomics

New York, New York, United Statesfitbiomics.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

FitBiomics has developed clinically validated probiotics like Nella and V•Nella, focusing on gut health, sleep, and endurance. Their research involves analyzing the microbiome of elite athletes to identify beneficial bacteria.

Therapeutic areas: OtherPsychiatryGastroenterologyCardiovascularNeurologyWomen's Health
Modalities: Probiotics
Industry: Food & Nutrition

Drug pipeline

2 assets

Nella

Commercial

Indications: Sleep disorders, Digestive disorders

1 more asset in the full pipeline.

Request access →

Partnerships

Wyss Institute for Biologically Inspired Engineering at Harvard University

Beyond the preview

Go deeper on FitBiomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FitBiomics.

Explore the full profile